AU Patent

AU2009249154A1 — Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same

Assigned to Incyte Holdings Corp · Expires 2009-11-26 · 16y expired

What this patent protects

Patent listed against capmatinib-hydrochloride.

Drugs covered by this patent

capmatinib-hydrochloride (CAPMATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: AU2009249154A1
Jurisdiction: AU
Classification: —
Expires: 2009-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Incyte Holdings Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.